TCIM
NTUS

TIAA CREF Investment Management’s Natus Medical Inc NTUS Stock Holding History

TIAA CREF Investment Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.61M Sell
63,570
-3,163
-5% -$94.4K ﹤0.01% 2103
2018
Q4 		$2.27M Sell
66,733
-824
-1% -$26.8K ﹤0.01% 1884
2018
Q3 		$2.41M Sell
67,557
-5,389
-7% -$190K ﹤0.01% 2028
2018
Q2 		$2.52M Sell
72,946
-2,794
-4% -$97.9K ﹤0.01% 2044
2018
Q1 		$2.55M Sell
75,740
-8,416
-10% -$266K ﹤0.01% 1983
2017
Q4 		$3.21M Sell
84,156
-56,641
-40% -$2.26M ﹤0.01% 1875
2017
Q3 		$5.28M Sell
140,797
-77,509
-36% -$2.74M ﹤0.01% 1589
2017
Q2 		$8.14M Buy
218,306
+458
+0.2% +$16.5K 0.01% 1263
2017
Q1 		$8.55M Buy
217,848
+32,800
+18% +$1.23M 0.01% 1223
2016
Q4 		$6.44M Buy
185,048
+5,873
+3% +$231K ﹤0.01% 1433
2016
Q3 		$7.04K Buy
179,175
+12,269
+7% +$489K ﹤0.01% 1366
2016
Q2 		$6.31M Sell
166,906
-32,382
-16% -$1.08M ﹤0.01% 1376
2016
Q1 		$7.66M Buy
199,288
+19,809
+11% +$738K 0.01% 1215
2015
Q4 		$8.62M Sell
179,479
-16,811
-9% -$778K 0.01% 1163
2015
Q3 		$7.74M Sell
196,290
-61,169
-24% -$2.6M 0.01% 1217
2015
Q2 		$11M Buy
257,459
+17,785
+7% +$709K 0.01% 1088
2015
Q1 		$9.46M Sell
239,674
-4,189
-2% -$154K 0.01% 1183
2014
Q4 		$8.79M Sell
243,863
-5,929
-2% -$199K 0.01% 1208
2014
Q3 		$7.37M Sell
249,792
-3,037
-1% -$83.8K 0.01% 1318
2014
Q2 		$6.36M Buy
252,829
+10,433
+4% +$258K ﹤0.01% 1496
2014
Q1 		$6.25M Buy
242,396
+46,873
+24% +$1.18M ﹤0.01% 1455
2013
Q4 		$4.4M Sell
195,523
-5,935
-3% -$115K ﹤0.01% 1722
2013
Q3 		$2.86M Sell
201,458
-1,672
-0.8% -$22.4K ﹤0.01% 1981
2013
Q2 		$2.77M Buy
+203,130
New +$2.77M ﹤0.01% 1956

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TIAA CREF Investment Management's NTUS Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Natus Medical Inc (NTUS) stake by 4.7% in Q1 2019, selling an estimated $94.4K and leaving 63,570 shares worth $1.61M. The position accounts for ﹤0.01% of the portfolio, ranked #2103.

TIAA CREF Investment Management first reported a position in NTUS in Q2 2013 and has held it in 24 quarters since. The position peaked at $11M in Q2 2015. 168 funds tracked by Wall St. Rank hold NTUS as of Q1 2019.

  • TIAA CREF Investment Management held 63,570 shares of Natus Medical Inc worth $1.61M as of Q1 2019.
  • TIAA CREF Investment Management sold 3,163 Natus Medical Inc shares in Q1 2019, an estimated $94.4K.
  • Natus Medical Inc made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2103 holding.
  • TIAA CREF Investment Management first reported a position in Natus Medical Inc in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Natus Medical Inc position peaked at $11M in Q2 2015.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.